Skip to content

Effects of neuromuscular electrical stimulation on quadriceps muscle strength -Trial for cardiovascular surgery patients-

Effects of neuromuscular electrical stimulation on quadriceps muscle strength -Trial for cardiovascular surgery patients- - Effects of neuromuscular electrical stimulation on quadriceps muscle strength -Trial for cardiovascular surgery patients-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036759
Enrollment
20
Registered
2019-05-15
Start date
2018-06-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina, valvular disease

Interventions

Electromyoelectric stimulation is performed 5 times a week for 30 minutes a day from the first postoperative day to discharge from the hospital. Carry out rehabilitation after cardiovascular surgery.

Sponsors

Otemae Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Person planning coronary artery bypass graft surgery (CABG) or valvular surgery 70 years old or older

Exclusion criteria

Exclusion criteria: Person who has ever experienced neuromuscular electrical stimulation Person performing dialysis Person who is operating implanted electrodes such as pacemakers Person presenting sense loss in upper and lower limbs Patients who have open wounds or skin allergic symptoms at the treatment site Persons who explained the purpose of this research and did not obtain written consent from the patient or the representative Person who the investigative doctor or research director judged as inappropriate as a subject

Design outcomes

Primary

MeasureTime frame
Knee extension strength

Secondary

MeasureTime frame
Grip strength Quadriceps muscle thickness Short Physical Performance Battery 6 minute walk test

Countries

Japan

Contacts

Public Contactyuki kakimoto

Otemae Hospital Clinical Research Center Clinical Trials Office

y.kakimoto29@outlook.com06-6941-0484

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026